Physician profile
Andrew Schmierer
NPI 1700854700
$491.01
in general payments reported to CMS, 2019-2025
10 companies · $75.33 in 2025
The $75.33 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.51 · 2021: $178 · 2022: $36.44 · 2024: $167 · 2025: $75.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $196.21 | 2021-2025 | Prostep Mica |
| Smith+Nephew, INC. | $149.76 | 2024 | Grafix Pl, Oasis, Stravix Pl |
| Acera Surgical, INC. | $36.44 | 2022 | |
| Orthofix Medical, INC. | $21.75 | 2025 | Physio-Stim |
| Bioventus LLC | $20.71 | 2021 | |
| Averitas Pharma INC. | $17.06 | 2024 | Qutenza |
| Grt US Holding, INC. | $14.57 | 2021 | |
| Celularity INC. | $12.00 | 2019 | |
| Sandoz INC. | $11.52 | 2019 | |
| Paragon 28, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schmierer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.